COMMUNIQUÉS West-GlobeNewswire

Disclosure of notification received from FMR LLC

26/11/2024 - 18:59

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM CET Disclosure of notification received from FMR LLC Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of [...]

iTeos annonce sa participation aux prochaines journées Investisseurs

26/11/2024 - 17:53

WATERTOWN, Massachusetts et GOSSELIES, Belgique, 26 nov. 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS), une société biopharmaceutique au stade clinique, pionnière dans la découverte et le [...]

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

26/11/2024 - 17:45

To potentially include adolescents and antibody persistence up to two years Saint Herblain (France), November 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that [...]

Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ®

26/11/2024 - 17:45

Avec pour objectif l’extension de l’utilisation aux adolescents et l’inclusion de la persistance des anticorps jusqu’à deux ans Saint Herblain (France), le 26 novembre 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: [...]

Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

26/11/2024 - 17:00

HOUSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of [...]

Spectral AI Announces Repricing of its Public Warrants

26/11/2024 - 16:17

DALLAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more [...]

WellRithms Co-founder and President, Anna Quarum, Honored at the 17th Annual 2024 Globee® Awards for Achievement – ‘Women in Business’

26/11/2024 - 16:03

PORTLAND, Ore., Nov. 26, 2024 (GLOBE NEWSWIRE) -- WellRithms , an industry-leading payment integrity firm, proudly announces that Anna Quarum, co-founder and president, has received a Silver award at the 17th Annual [...]

SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia

26/11/2024 - 16:01

• SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. • Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS [...]

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

26/11/2024 - 16:00

Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment HOUSTON, TX, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ( [...]

Nelipak Healthcare Packaging Opens First North American Flexible Packaging Production Site

26/11/2024 - 16:00

New North Carolina Site Expands Nelipak’s Capabilities in the Americas Region CRANSTON, R.I., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading global provider of packaging solutions for [...]

Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

26/11/2024 - 15:05

SEATTLE, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of CAR-T cells, today [...]

Stem Cells, Superstars, And Supershow: WWE Superstar Elias Set to Face Off at WrestleCade SuperShow 2024 This Weekend

26/11/2024 - 15:00

WINTER PARK, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is proud to announce that this weekend, Jeff Sciullo, known in the wrestling world as Elias from WWE and business partner to ADIA [...]

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

26/11/2024 - 15:00

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]

Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

26/11/2024 - 14:45

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]

Jeanette Fritsch Expands SIMPLY-HEALTH Platform to Offer Comprehensive Menopause Solutions for Midlife Professionals

25/11/2024 - 22:55

Jeanette Fritsch expands her SIMPLY-HEALTH platform, offering tailored menopause solutions for midlife professionals through her SRB&B® method. These programs target hormonal balance, enhancing vitality and [...]

Travere Therapeutics to Present at Upcoming Investor Conferences

25/11/2024 - 22:30

SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in December: 7 th Annual [...]

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

25/11/2024 - 22:30

BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer [...]

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

25/11/2024 - 22:15

SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic [...]

Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering

25/11/2024 - 22:15

SAN DIEGO and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]